WO2005089719A1 - Polish compositions - Google Patents

Polish compositions Download PDF

Info

Publication number
WO2005089719A1
WO2005089719A1 PCT/IB2004/000405 IB2004000405W WO2005089719A1 WO 2005089719 A1 WO2005089719 A1 WO 2005089719A1 IB 2004000405 W IB2004000405 W IB 2004000405W WO 2005089719 A1 WO2005089719 A1 WO 2005089719A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
composition
polish
polish composition
polyethylene glycol
Prior art date
Application number
PCT/IB2004/000405
Other languages
French (fr)
Inventor
Suresh Pareek
Ashok Mohanty
Jiten Surve
Original Assignee
Ideal Cures Pvt.Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ideal Cures Pvt.Ltd. filed Critical Ideal Cures Pvt.Ltd.
Priority to PCT/IB2004/000405 priority Critical patent/WO2005089719A1/en
Publication of WO2005089719A1 publication Critical patent/WO2005089719A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/2853Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)

Definitions

  • This invention is in the field of polish compositions for edible substrates comprising of polyethylene glycol and /or its analogs, a plasticizer, a film former, a film detackifier and a glidant.
  • the composition can be used as a dry powder, or as an aqueous or non-aqueous suspension. Coating of substrates with the above composition imparts a glossy and shining appearance to the coated substrates and thus reduces the frictional effects between individual substrate particles after coating. This results in lesser chipping or fragmentation of the substrate during packaging, which is performed after coating and thus retains the integrity of the coated substrate by minimizing the frictional effects during subsequent operations.
  • wax polish compositions are solutions of wax in an organic solvent such as carbon tetrachloride or ether.
  • organic solvent such as carbon tetrachloride or ether.
  • these solvents give rise to processing problems because of their toxic, inflammable and non-environmental friendly nature.
  • inadvertent over use of wax based solutions may spoil the substrate by adhesion of excess wax to the surface.
  • Conventional wax polishing using an aqueous based system may result in spoiling the surface of the substrate due to over-washing.
  • U . S.Pat Nos.3438794, 5023108, 5389129, 5733575, 6013282, 6039976 and WO0109259 all discuss wax based polish compositions with their advantages.
  • the present invention provides a polish composition that is not wax based and has the following advantages.
  • the composition can be used as a powder and as a reconstituted suspension.
  • the reconstitution can be in an aqueous or non-aqueous solvent or mixtures thereof.
  • composition of the present invention comprises of a polyethylene glycol, plasticizer, film former, detackifier and a glidant.
  • the polish composition of the present invention may contain a suitable preservative active in the range of pH 3.0 to 7.0 and acceptable for food/pharmaceutical use.
  • composition of our present invention is:
  • HPMC Hydroxypropylmethylcellulose
  • the substrates are to be rotated in the coating pan after spraying is complete for atleast 15 minutes till they are completely dried.
  • the solid content of the solution and the weight gain during coating may be varied depending on the substrate and the desired final product.
  • the preferred composition may be reconstituted in a non-aqueous medium as follows: Prepare an non-aqueous suspension of the above composition at a concentration of 0.2% of the total weight of the tablets to be coated and prepare a 5% solution in a mixture of Isopropyl alcohol and dichloromethane by dispersing the dry polish composition in isopropyl alcohol under stirring and adding dichloromethane during stirring for a period of at least 10 minutes till a uniform suspension is formed. Coat the substrate by the process of spraying the polishing suspension onto the substrates under the following coating parameters:
  • the substrates are to be rotated in the coating pan after spraying is complete for atleast 15 minutes till they are completely dried.
  • the preferred composition may be reconstituted in a hydro-alcoholic medium as follows:
  • % friability gives an indication of the physical pressures that a tablet can withstand during further processising and there is a limit of 1 % so that product specifications are adhered to and the patient gets a quality product.
  • Examples 6-8 reveal the comparative % friability results obtained on unpolished tablets vis-a-vis that for the tablets polished with the dry polish composition of the present invention.
  • the % friability is a very important factor in case of low dose drug products as even a marginal loss can lead to a large compromise in dosage and the product will not comply with the compendial standards.

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)

Abstract

This invention is in the field of polish compositions for edible substrates comprising of polyethylene glycol and /or its analogs, a plasticizer, a film former, a film detackifier and a glidant. Coating of substrates with the above composition imparts to the substrate a glossy appearance, reduces inter substrate friction and helps to minimize losses during packaging of the finished product.

Description

POLISH COMPOSITION
FIELD OF THE INVENTION
This invention is in the field of polish compositions for edible substrates comprising of polyethylene glycol and /or its analogs, a plasticizer, a film former, a film detackifier and a glidant. The composition can be used as a dry powder, or as an aqueous or non-aqueous suspension. Coating of substrates with the above composition imparts a glossy and shining appearance to the coated substrates and thus reduces the frictional effects between individual substrate particles after coating. This results in lesser chipping or fragmentation of the substrate during packaging, which is performed after coating and thus retains the integrity of the coated substrate by minimizing the frictional effects during subsequent operations.
Description of Prior Art
The present invention relates to a non-wax polish composition, used for coating of substrates, wherein the sunstrates are pharmaceutical dosage forms or confectionery piece.
Conventional wax polish compositions are solutions of wax in an organic solvent such as carbon tetrachloride or ether. However, these solvents give rise to processing problems because of their toxic, inflammable and non-environmental friendly nature. Moreover, inadvertent over use of wax based solutions may spoil the substrate by adhesion of excess wax to the surface. Conventional wax polishing using an aqueous based system may result in spoiling the surface of the substrate due to over-washing. U.S.Pat Nos.3438794, 5023108, 5389129, 5733575, 6013282, 6039976 and WO0109259 all discuss wax based polish compositions with their advantages. However it would be ideal to have a non-wax based polish composition capable of giving the same effect as that given by a wax based composition to avoid all the disadvantages of wax based compositions. The present invention provides a polish composition that is not wax based and has the following advantages.
1. The composition can be used as a powder and as a reconstituted suspension.
2. The reconstitution can be in an aqueous or non-aqueous solvent or mixtures thereof.
3. It can be used in varying concentrations
4. It gives a gloss to the substrate that is similar to the one achieved with a wax based composition
5. It decreases thee frictional effects between the substrates and thus reduces losses due to mechanical factors during later operations like packaging
6. It helps to minimize the losses during packing and thus increases the overall yield efficiency during manufacture.
The composition of the present invention comprises of a polyethylene glycol, plasticizer, film former, detackifier and a glidant.
Optionally, the polish composition of the present invention may contain a suitable preservative active in the range of pH 3.0 to 7.0 and acceptable for food/pharmaceutical use.
The most preferred composition of our present invention is:
Polyethylene Glycol 6000 97.6%
Glycerin 2.0%
Hydroxypropylmethylcellulose (HPMC) 0.2%
Talc 0.2%
Preparation / Reconstitution of the dry polish composition:
Prepare an aqueous suspension of the above composition at a concentration of 0.2% of the total weight of the tablets to be coated and prepare a 20% solution in demineralized water by stirring it in water under stirring and then stir for a period of atleast 10 minutes till a uniform suspension is formed. Coat the substrate by the process of spraying the polishing suspension onto the substrates under the following coating parameters. Temperature of tablet bed at the beginning of spraying - 27 to 50 deg C. Inlet Air Blower and Temperature - Switch Off during spraying the polish suspension. Temperature after spraying - 65 to 70 deg C.
The substrates are to be rotated in the coating pan after spraying is complete for atleast 15 minutes till they are completely dried.
The solid content of the solution and the weight gain during coating may be varied depending on the substrate and the desired final product.
The preferred composition may be reconstituted in a non-aqueous medium as follows: Prepare an non-aqueous suspension of the above composition at a concentration of 0.2% of the total weight of the tablets to be coated and prepare a 5% solution in a mixture of Isopropyl alcohol and dichloromethane by dispersing the dry polish composition in isopropyl alcohol under stirring and adding dichloromethane during stirring for a period of at least 10 minutes till a uniform suspension is formed. Coat the substrate by the process of spraying the polishing suspension onto the substrates under the following coating parameters:
Temperature of tablet bed at the beginning of spraying - 28 to 40 deg C. Inlet Air Blower and Temperature - Switch Off during spraying the polish suspension.
Temperature after spraying - 55 to 65deg C.
The substrates are to be rotated in the coating pan after spraying is complete for atleast 15 minutes till they are completely dried.
The solid content of the solution and the weight gain during coating may be varied depending on the substrate and the desired final product.
The preferred composition may be reconstituted in a hydro-alcoholic medium as follows:
Prepare a hydro-alcoholic suspension of the above composition at a concentration of
0.2% of the total weight of the tablets to be coated and prepare a 20% solution by dispersing the dry polish composition in water and adding isopropyl alcohol under stirring, followed by stirring for a period of at least 10 minutes till a uniform suspension is formed. Coat the substrate by the process of spraying the polishing suspension onto the substrates under the following coating parameters: Temperature of tablet bed at the beginning of spraying - 28 to 45 deg C. Inlet Air Blower and Temperature Switch Off during spraying the polish suspension.
Temperature after spraying - 65 to 75deg C.
The substrates are to be rotated in the coating pan after spraying is complete for atleast 15 minutes till they are completely dried.
The solid content of the solution and the weight gain during coating may be varied depending on the substrate and the desired final product.
As mentioned in the advantages earlier the following examples reveal the comparative results in terms of the percentage loss seen after packing (either blister or strip) of core, placebo and coated tablets vis a vis tablets (core, placebo and coated) polished with the composition of the present invention:
EXAMPLE 2:
Gl impend e Tablets 1 mg
Batch Size: 1,00,000 nos. tablets
Packing of Unpolished Tablets Polished Tablets
Glimperide 1 mg Tablets 98,500 nos. 99,300 nos.
Percentage Loss 1.5 % 0.7 %
EXAMPLE 3:
Cetirizine HC1 Tablets 10 Mg
Batch Size : 1,00,000 nos. tablets
Packing of Film Coated Tablets Film Coated & Polished Tablets
Cetirizine HC1 Tablets 10 Mg 98,800 nos. 99,500 nos.
Percentage Loss 1.2 % 0.5 % Example 4 :
Placebo Tablets
Batch Size : 1,00,000 nos. tablets
Packing of Core tablets Polished Tablets Placebo Tablets 98,500 nos. 99,700 nos. Percentage Loss 1.5 % 0.3 %
Example 5 :
Film Coated Placebo Tablets
Batch Size : 1,00,000 nos. tablets
Packing of Core tablets Polished Tablets
Film Coated Placebo Tablets 98,800 nos. 99,700 nos.
Percentage Loss 1.2 % 0.3 %
It can be seen above from the examples 2-5 that in case of all batches wherein the substrates were coated with the dry polish composition, the percentage loss during packing was much less and higher batch yields for the process were obtained.
To evaluate the losses that arise during friction between substrates friability is a test that is prescribed by the USP. The % friability gives an indication of the physical pressures that a tablet can withstand during further processising and there is a limit of 1 % so that product specifications are adhered to and the patient gets a quality product.
Examples 6-8 reveal the comparative % friability results obtained on unpolished tablets vis-a-vis that for the tablets polished with the dry polish composition of the present invention.
EXAMPLE 6: Glimperide Tablets 1 mg Batch Size: 1,00,000 nos. tablets Unpolished Tablets Polished Tablets
Friability 0.4 % 0.1 % EXAMPLE 7:
Cetirizine HC1 Tablets 10 Mg
Batch Size : 1,00,000 nos. tablets Unpolished Tablets Polished Tablets
Friability 0.5 % 0.2 %
Example 8 :
Placebo Tablets
Batch Size : 1,00,000 nos. tablets Unpolished Tablets Polished Tablets
Friability 0.4 % 0.15 %
As seen from the comparative data in Examples 6-7 it can be seen that there is a fall in % friability for substrates coated with the composition of the present invention. This maybe attributed to the lower incidence of frictional effects because of easy intra and inter paniculate sliding due to the polishing effect.
The % friability is a very important factor in case of low dose drug products as even a marginal loss can lead to a large compromise in dosage and the product will not comply with the compendial standards.

Claims

CLAIMS: We claim:
1. A polish composition for coating edible substrates to impart a gloss thereto, consisting essentially of at least 50% by weight of a polyethylene glycol or its analog, 0-15% by weight of a plasticizer, 0-10% by weight of a cellulosic film former, 0-5% by weight of a detackifier and 0-5% by weight of a glidant.
2. A polish composition according to claim 1, wherein the edible substrate is a pharmaceutical dosage form or a food / confectionery item.
3. A polish composition according to claim 1, in which the polyethylene glycol is polyethylene glycol 6000.
4. A polish composition according to claim 1, in which the composition of polyethylene glycol or its analog is atleast 50% by weight of the composition.
5. A polish composition according to claim 1, in which the plasticizer is glycerin.
6. A polish composition according to claim 1, in which the composition of the plasticizer is from about 0-15% by weight of the composition.
7. A polish composition according to claim 1, in which the cellulosic film former is hydroxypropylmethylcellulose.
8. A polish composition according to claim 1, in which the composition of the film-former is from about 0-10% by weight of the composition.
9. A polish composition according to claim 1 , in which the detackifier is talc.
10. A polish composition according to claim 1, in which the composition of the detackifier is from about 0-5% by weight of the composition.
11. A polish composition according to claim 1, in which the glidant is talc.
12. A polish composition according to claim 1, in which the composition of the glidant is from about 0-5% by weight of the composition.
13. A polish composition for coating edible substrates to impart a gloss thereto, consisting essentially of at least 50% by weight of a polyethylene glycol or its analog, 0-15% by weight of a plasticizer, 0-10% by weight of a cellulosic film former, 0-5% by weight of a detackifier, 0-5% by weight of a glidant and optionally a preservative from 0.15 to 0.75% by weight of the composition.
14. A polish composition as in claim 13, wherein the preservative is active in the range of pH 3.0 to 7.0 and is acceptable for food / pharmaceutical use.
15. A method of decreasing the percentage losses before final packaging of a substrate by using a polish composition, consisting essentially of at least 50% by weight of a polyethylene glycol or its analog, 0-15% by weight of a plasticizer, 0-10% by weight of a cellulosic film former, 0-5% by weight of a detackifier and 0-5% by weight of a glidant.
16. A method of reducing friability for substrates which are pharmaceutical dosage forms by coating them with the polish composition, consisting essentially of at least 50% by weight of a polyethylene glycol or its analog, 0-15% by weight of a plasticizer, 0-10% by weight of a cellulosic film former, 0-5% by weight of a detackifier and 0-5% by weight of a glidant.
17. A process for preparing a polish composition by dry blending of ingredients in a food processor or "V" blender, the ingredients consisting essentially of at least 50% by weight of a polyethylene glycol or its analog, 0-15% by weight of a plasticizer, 0-10% by weight of a cellulosic film former, 0-5% by weight of a detackifier and 0-5% by weight of a glidant.
PCT/IB2004/000405 2004-02-25 2004-02-25 Polish compositions WO2005089719A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/IB2004/000405 WO2005089719A1 (en) 2004-02-25 2004-02-25 Polish compositions

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2004/000405 WO2005089719A1 (en) 2004-02-25 2004-02-25 Polish compositions

Publications (1)

Publication Number Publication Date
WO2005089719A1 true WO2005089719A1 (en) 2005-09-29

Family

ID=34993422

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2004/000405 WO2005089719A1 (en) 2004-02-25 2004-02-25 Polish compositions

Country Status (1)

Country Link
WO (1) WO2005089719A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683256A (en) * 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
US5882707A (en) * 1996-01-05 1999-03-16 Bpsi Holdings, Inc. Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
US6013282A (en) * 1994-10-07 2000-01-11 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US6448323B1 (en) * 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
US20030017204A1 (en) * 1999-02-08 2003-01-23 Michael Augello Edible coating composition

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683256A (en) * 1980-11-06 1987-07-28 Colorcon, Inc. Dry edible film coating composition, method and coating form
US6013282A (en) * 1994-10-07 2000-01-11 Bpsi Holdings, Inc. Enteric film coating compositions, method of coating therewith, and coated forms
US5882707A (en) * 1996-01-05 1999-03-16 Bpsi Holdings, Inc. Method of coating an edible substrate with sugar/syrup or sugarless solutions containing dry color concentrate
US20030017204A1 (en) * 1999-02-08 2003-01-23 Michael Augello Edible coating composition
US6448323B1 (en) * 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol

Similar Documents

Publication Publication Date Title
KR101145013B1 (en) Film-forming starchy composition
TW419370B (en) Stabilized pharmaceutical compositions comprising bupropion hydrochloride and their preparation process
JP6304234B2 (en) Coating composition, coating preparation and method for producing the same
TWI451879B (en) Selected from the group consisting of D- alanine and D- hydroxy-proline, the above groups and D- alanine and proline salts of D- hydroxy consisting of one kind or two kinds of the compound for the production of laminin 332 the use of production Accelerating composition
JPH05508667A (en) Water-based maltodextrin and cellulose polymer film coating
JP6911900B2 (en) Coating formulation and its manufacturing method
CA2316981C (en) Pharmaceutical composition containing bupropion hydrochloride and a stabilizer
US20060013875A1 (en) Combination immediate release controlled release levodopa/carbidopa dosage forms
US5968553A (en) Pharmaceutical composition containing bupropion hydrochloride and an inorganic acid stabilizer
CN107669683B (en) Pharmaceutical composition containing sitagliptin and metformin
KR20050086767A (en) Water-based shellac coating material, process for producing the same, coated food obtained with the coating material, process for producing the same, coated medicine, process for producing the same, glazing composition for oily snack, method of glazing, and glazed oily snack
JP2005027651A (en) Aqueous shellac coating, method for producing the coating, coated food, method for producing the food, coated pharmaceutical, and method for producing the pharmaceutical
JP7111104B2 (en) Coating composition, coating film, coating formulation and method for producing the same
KR102483912B1 (en) Method for producing soft capsule type functional health food
TW201545742A (en) Solid molecular dispersion
WO2005089719A1 (en) Polish compositions
US4828839A (en) Method for making a guar flour chewable dosage unit
Babich et al. The effectiveness of plant hydrocolloids at maintaining the quality characteristics of the encapsulated form of L-phenylalanine-ammonia-lyase
JP2006176496A (en) Solid agent and process for producing the same
JP2010189378A (en) Film-coated sublimable component-containing solid preparation
CN110151725B (en) Stable rosuvastatin calcium capsule and preparation method thereof
JPS6084215A (en) Film coating composition for solid pharmaceutical
CN113456639A (en) Anti-arrhythmia pharmaceutical composition and preparation method thereof
AU3966793A (en) Aminoguanidine spray drying process
KR102163637B1 (en) Method for producing functional health food

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1090/MUMNP/2006

Country of ref document: IN

122 Ep: pct application non-entry in european phase